Eclipta Pharmaceutical Private Limited
About Eclipta Pharmaceutical Private Limited
Data last updated:
Eclipta Pharmaceutical Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74900MP2015PTC035070. Its GSTIN is 23AAECE3355M1ZL (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Neetu Singh and Satyendra Naroni Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 184 G – 1 Kanyakubj Nagar, Indore, Madhya Pradesh, India – 452005.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.96 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹87,410 (net margin 0.4%) and EBITDA of ₹2.26 Lakh (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years and 35% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Eclipta Pharmaceutical Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 184 G – 1 Kanyakubj Nagar, Indore, Madhya Pradesh, India – 452005
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Eclipta Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Eclipta Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Eclipta Pharmaceutical Private Limited, buy the company report.
Financials of Eclipta Pharmaceutical Private Limited
FY 2025 filings availableEclipta Pharmaceutical Private Limited reported revenue of ₹1.96 Cr (up 36% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 35% over five years, including 36% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹87,410 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eclipta Pharmaceutical Private Limited, buy the company report.
Board of directors of Eclipta Pharmaceutical Private Limited
Eclipta Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neetu Singh | Director | 10 Dec 2015 | 10 Years 10 Months | Current |
| Satyendra Naroni Singh | Director | 10 Dec 2015 | 10 Years 10 Months | Current |
Peer comparison
Eclipta Pharmaceutical Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Piyatho Health Care Private Limited | ₹1.97 Cr (FY 2024) | 206.0% | Ernakulam, Kerala, India | |||
| R.S.Pathy Naturo Private Limited | ₹1.97 Cr (FY 2025) | -6.0% | Madurai, Tamil Nadu, India | |||
| Generic Supermart India Private Limited | ₹1.97 Cr (FY 2025) | 23.0% | Indore, Madhya Pradesh, India | |||
| Eclipta Pharmaceutical Private Limitedthis company | ₹1.96 Cr (FY 2025) | ₹87,410 | 0.4% | 36.0% | Indore, Madhya Pradesh, India | |
| SCJ Traders Private Limited | ₹1.96 Cr (FY 2024) | 395.0% | Muzaffarnagar, Uttar Pradesh, India | |||
| Mutual Pharma Private Limited | ₹1.96 Cr (FY 2017) | -39.0% | Gurgaon, Haryana, India |
To see the full peer comparison of Eclipta Pharmaceutical Private Limited, buy the company report.
Auditor
Eclipta Pharmaceutical Private Limited is audited by V.Kasat & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.Kasat & Co. | FY 2023 | 010912C |
Shareholding
The shareholding of Eclipta Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Eclipta Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Eclipta Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eclipta Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Eclipta Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAECE3355M1ZL | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Eclipta Pharmaceutical Private Limited, buy the company report.
Recent activity
Eclipta Pharmaceutical Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Neetu Singh was appointed as Director on 10 Dec 2015.
Frequently asked questions
Eclipta Pharmaceutical is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 December 2015 (11+ years old) and is registered under CIN U74900MP2015PTC035070.
Eclipta Pharmaceutical has 2 current directors:
- Neetu Singh - Director
- Satyendra Naroni Singh - Director
The latest financial statements of Eclipta Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Eclipta Pharmaceutical is 23AAECE3355M1ZL, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Eclipta Pharmaceutical is U74900MP2015PTC035070. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eclipta Pharmaceutical was incorporated on 10 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Eclipta Pharmaceutical by revenue are Piyatho Health Care Private Limited, R.S.Pathy Naturo Private Limited, Generic Supermart India Private Limited, SCJ Traders Private Limited, Mutual Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Neetu Singh was appointed as Director on 10 Dec 2015. Satyendra Naroni Singh was appointed as Director on 10 Dec 2015.
The registered office of Eclipta Pharmaceutical is at Plot No. 184 G – 1 Kanyakubj Nagar, Indore, Madhya Pradesh, India – 452005.
Eclipta Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Eclipta Pharmaceutical is compliant as of 08 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
